Article

Bausch + Lomb unveils updates for vision enhancement system

The first in a series of upgrades to Stellaris Elite incudes maximum vacuum increase and trocar/cannula system removeable valve cap enhancement.

Bausch + Lomb Corp. today announced the first in a series of efficiency-enhancing upgrades for the Stellaris Elite vision enhancement system. The upgrades include an increase to the maximum vacuum setting from 600 to 660mmHg and an enhancement to the removable valve caps in the trocar/cannula system.

“Bausch + Lomb is continuously innovating with the twin goals of delivering new technologies and strengthening our existing portfolio,” Anthony Wallace, vice president and general manager, U.S. Surgical, Bausch + Lomb, said in a statement. “These upgrades represent the first in a series of multiple enhancements planned for the Stellaris Elite platform, all of which will focus on key tenets of vitreoretinal surgery – vitreous and tissue removal, visualization and fluidics.”

The company noted in a news release that the maximum vacuum increase enables a 10% boost in vacuum capabilities and up to an 8% increase in vitreous removal efficiency. The changes made to the removable valve caps in the trocar/cannula system deliver a 33% increase in the central thickness of the valve and a 27% reduction in each segment of the familiar tri-slit profile.

Moreover, the company added that these changes are designed to provide improved fluidic stability during vitrectomy surgery. Both the vacuum increase and the changes to the trocar/cannula system will be made available to Stellaris Elite users beginning this month.

“As a Stellaris Elite user since its inception, I have come to rely on its fluidic predictability and excellent precision and efficiency in the operating room,” said Rahul K. Reddy, MD, an ophthalmologist and retinal specialist, Associated Retina Consultants, Phoenix, Arizona. “These upgrades will further enhance this extremely stable platform and allow delicate maneuvers to continue to be performed. I look forward to the additional enhancements to come in the near future.”

Bausch + Lomb noted in its news release that completing this first round of enhancements will be an increase in light pipe rigidity. In 2020, the design of all of the company’s 25-gauge endoilluminators were altered to increase rigidity by 146%. Later this year, the 25-gauge endoilluminators will see a further 74% increase in rigidity for additional support in manipulating the globe.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.